Role of glutamine in cancer: Therapeutic and imaging implications

Journal of Nuclear Medicine

Volumn 52, Issue 7, 2011, Pages 1005-1008

  Rajagopalan, Kartik N ^a   DeBerardinis, Ralph J ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Glutamine; Metabolism; Oncology; PET; Warburg effect

Indexed keywords

6 DIAZO 5 OXONORLEUCINE; ANTINEOPLASTIC AGENT; BENZO[A]PHENANTHRIDINONE DERIVATIVE; BIS 2 (5 PHENYLACETAMIDO 1,2,4 THIADIAZOL 2 YL)ETHYL SULFIDE; GLUTAMINE; UNCLASSIFIED DRUG;

ACCURACY; AMINO ACID METABOLISM; ANTINEOPLASTIC ACTIVITY; CANCER CELL; CANCER INHIBITION; DRUG POTENCY; DRUG TARGETING; GENE MUTATION; HUMAN; MALIGNANT TRANSFORMATION; MOLECULAR IMAGING; NEOPLASM; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; ONCOGENE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; RELIABILITY; REVIEW; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

ANIMALS; GLUTAMINE; HUMANS; MOLECULAR IMAGING; NEOPLASMS;

EID: 79960329041     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.110.084244     Document Type: Review

References (30)

1. Deberardinis RJ, Sayed N, Ditsworth D, Thompson CB. Brick by brick: metabolism and tumor cell growth. Curr Opin Genet Dev. 2008;18:54-61. (Pubitemid 351694453)
2. Basu S, Alavi A. Molecular imaging (PET) of brain tumors. Neuroimaging Clin N Am. 2009;19:625-646.
3. Yu EY, Muzi M, Hackenbracht JA, et al. C11-acetate and F-18 FDG PET for men with prostate cancer bone metastases: relative findings and response to therapy. Clin Nucl Med. 2011;36:192-198.
4. Zhu A, Lee D, Shim H. Metabolic positron emission tomography imaging in cancer detection and therapy response. Semin Oncol. 2011;38:55-69.
5. Levine AJ, Puzio-Kuter AM. The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes. Science. 2010;330:1340-1344.
6. DeBerardinis RJ, Cheng T. Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer. Oncogene. 2010;29:313-324.
7. DeBerardinis RJ, Mancuso A, Daikhin E, et al. Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc Natl Acad Sci USA. 2007;104:19345-19350.
8. Meng M, Chen S, Lao T, Liang D, Sang N. Nitrogen anabolism underlies the importance of glutaminolysis in proliferating cells. Cell Cycle. 2010;9:3921-3932.
9. Gaglio D, Soldati C, Vanoni M, Alberghina L, Chiaradonna F. Glutamine deprivation induces abortive s-phase rescued by deoxyribonucleotides in k-ras transformed fibroblasts. PLoS ONE. 2009;4:e4715.
10. Lagranha CJ, Doi SQ, Pithon-Curi TC, Curi R, Sellitti DF. Glutamine enhances glucose-induced mesangial cell proliferation. Amino Acids. 2008;34:683-685.
11. Wellen KE, Lu C, Mancuso A, et al. The hexosamine biosynthetic pathway couples growth factor-induced glutamine uptake to glucose metabolism. Genes Dev. 2010;24:2784-2799.
12. Reitzer LJ, Wice BM, Kennell D. Evidence that glutamine, not sugar, is the major energy source for cultured HeLa cells. J Biol Chem. 1979;254:2669-2676. (Pubitemid 9196102)
13. Hu W, Zhang C, Wu R, Sun Y, Levine A, Feng Z. Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function. Proc Natl Acad Sci USA. 2010;107:7455-7460.
14. Wise DR, DeBerardinis RJ, Mancuso A, et al. Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction. Proc Natl Acad Sci USA. 2008;105:18782-18787.
15. Gao P, Tchernyshyov I, Chang TC, et al. c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature. 2009;458:762-765.
16. Yuneva M, Zamboni N, Oefner P, Sachidanandam R, Lazebnik Y. Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells. J Cell Biol. 2007;178:93-105. (Pubitemid 47026405)
17. Cadoret A, Ovejero C, Terris B, et al. New targets of beta-catenin signaling in the liver are involved in the glutamine metabolism. Oncogene. 2002;21:8293-8301. (Pubitemid 35477869)
18. Wang JB, Erickson JW, Fuji R, et al. Targeting mitochondrial glutaminase activity inhibits oncogenic transformation. Cancer Cell. 2010;18:207-219.
19. Seltzer MJ, Bennett BD, Joshi AD, et al. Inhibition of glutaminase preferentially slows growth of glioma cells with mutant IDH1. Cancer Res. 2010;70:8981-8987.
20. Dang L, White DW, Gross S, et al. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature. 2009;462:739-744.
21. Yang C, Sudderth J, Dang T, Bachoo RM, McDonald JG, DeBerardinis RJ. Glioblastoma cells require glutamate dehydrogenase to survive impairments of glucose metabolism or Akt signaling. Cancer Res. 2009;69:7986-7993.
22. 13N-ammonia PET: a new imaging method to diagnose hypopituitarism. J Nucl Med. 2005;46:44-47.
23. Qu W, Zha Z, Ploessl K, et al. Synthesis of optically pure 4-fluoro-glutamines as potential metabolic imaging agents for tumors. J Am Chem Soc. 2011;133:1122-1133.
24. 18F] fluoroglutamic acid (BAY 85-8050), a new amino acid radiotracer for PET imaging of tumors: synthesis and in vitro characterization. J Med Chem. December 3, 2010 [Epub ahead of print].
25. 1H MRS at 7T. NMR Biomed. 2010;23:1044-1052.
26. Street JC, Delort AM, Braddock PS, Brindle KM. A 1H/15N n.m.r. study of nitrogen metabolism in cultured mammalian cells. Biochem J. 1993;291:485-492. (Pubitemid 23127032)
27. Golman K, Ardenkjaer-Larsen JH, Petersson JS, Mansson S, Leunbach I. Molecular imaging with endogenous substances. Proc Natl Acad Sci USA. 2003;100:10435-10439. (Pubitemid 37071896)
28. Kurhanewicz J, Vigneron DB, Brindle K, et al. Analysis of cancer metabolism by imaging hyperpolarized nuclei: prospects for translation to clinical research. Neoplasia. 2011;13:81-97.
29. 13C-labeled glutamine. Magn Reson Med. 2008;60:253-257.
30. Gabellieri C, Reynolds S, Lavie A, Payne GS, Leach MO, Eykyn TR. Therapeutic target metabolism observed using hyperpolarized 15N choline. J Am Chem Soc. 2008;130:4598-4599. (Pubitemid 351500092)